Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BOLD
일자시간출처헤드라인심볼기업
2019/09/1705:18Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BOLDBoundless Bio Inc
2019/09/1005:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/09/1005:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/09/1005:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/09/0707:00Business WireAudentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BOLDBoundless Bio Inc
2019/08/2621:00PR Newswire (US)Audentes Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BOLDBoundless Bio Inc
2019/08/2405:03Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:BOLDBoundless Bio Inc
2019/08/1508:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/08/0719:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BOLDBoundless Bio Inc
2019/08/0705:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2019/08/0705:01PR Newswire (US)Audentes Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:BOLDBoundless Bio Inc
2019/08/0121:00PR Newswire (US)Audentes Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BOLDBoundless Bio Inc
2019/07/3021:00PR Newswire (US)Audentes Therapeutics to Release Second Quarter 2019 Financial Results and Provide Corporate Update on Tuesday, August 6, 201...NASDAQ:BOLDBoundless Bio Inc
2019/07/2007:00PR Newswire (US)Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BOLDBoundless Bio Inc
2019/07/1805:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/07/1805:25Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BOLDBoundless Bio Inc
2019/06/2905:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2019/06/2705:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/06/0807:00PR Newswire (US)Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BOLDBoundless Bio Inc
2019/06/0805:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/06/0805:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/06/0805:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/06/0805:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/06/0805:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2019/05/3005:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2019/05/3005:01PR Newswire (US)Audentes Therapeutics Announces Changes to Senior Management TeamNASDAQ:BOLDBoundless Bio Inc
2019/05/1606:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/05/1319:04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BOLDBoundless Bio Inc
2019/05/0821:00PR Newswire (US)Audentes Therapeutics to Participate in the Bank of America Merrill Lynch 2019 Health Care ConferenceNASDAQ:BOLDBoundless Bio Inc
2019/05/0819:43Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BOLDBoundless Bio Inc
 검색 관련기사 보기:NASDAQ:BOLD